| Name | NBI-98854 |
|---|
| Description | NBI-98854 is a potent, highly selective, VMAT2 inhibitor that is effective in regulating the levels of dopamine release during nerve communication.IC50 value:Target: VMAT2NBI-98854 completed a Phase I single ascending dose clinical trial in healthy male volunteers in Canada under an approved Clinical Trial Application with Health Canada.This trial showed NBI-98854 to be generally safe and well tolerated. |
|---|---|
| Related Catalog | |
| References |
[1]. NBI-98854 - Vesicular Monoamine Transporter 2 Inhibitor (VMAT2). |
| Melting Point | 167-170°C |
|---|---|
| Molecular Formula | C19H29NO3 |
| Molecular Weight | 319.44 |
| Storage condition | Refrigerator |